Literature DB >> 17045396

Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis.

D R D'Souza1, J Wei, Q Shao, M D Hebert, S H Subramony, P J S Vig.   

Abstract

Transglutaminase type 2 (TG2) has recently been implicated in crosslinking of mutant huntingtin protein into aggregates. Here we show that TG2 also crosslinks spinocerebellar ataxia-1 (SCA1) gene product ataxin-1. HeLa cell lysates expressing GFP tagged ataxin-1 with 2, 30 or 82 glutamines showed covalent crosslinking of ataxin-1 when incubated with exogenously added TG2. This crosslinking was inhibited by TG2 inhibitor cystamine. SCA1 transgenic mice which overexpress the mutant ataxin-1 in cerebellar Purkinje cells showed elevated nuclear TG2 in the absence of ataxin-1 nuclear aggregates. The addition of purified TG2 to the nuclear extracts or addition of SCA1 nuclear TG2 to GFP-Q82 HeLa cell lysates resulted in the formation of insoluble aggregates. These data indicate that ataxin-1 is a substrate of TG2. Further, in SCA1 TG2 may translocate to the nucleus in response to nuclear accumulation of mutant ataxin-1 at early stages of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17045396      PMCID: PMC2117902          DOI: 10.1016/j.neulet.2006.08.003

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  26 in total

1.  Evidence for a recruitment and sequestration mechanism in Huntington's disease.

Authors:  E Preisinger; B M Jordan; A Kazantsev; D Housman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 2.  Transglutaminases in neurodegenerative disorders.

Authors:  Craig D C Bailey; Janusz Tucholski; Gail V W Johnson
Journal:  Prog Exp Tumor Res       Date:  2005

3.  RNA association and nucleocytoplasmic shuttling by ataxin-1.

Authors:  Stuart Irwin; Mark Vandelft; Deborah Pinchev; Jenny L Howell; Joanna Graczyk; Harry T Orr; Ray Truant
Journal:  J Cell Sci       Date:  2005-01-01       Impact factor: 5.285

4.  Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3.

Authors:  Gina M Zainelli; Nichole L Dudek; Christopher A Ross; Soo-Youl Kim; Nancy A Muma
Journal:  J Neuropathol Exp Neurol       Date:  2005-01       Impact factor: 3.685

5.  Peptide models for inherited neurodegenerative disorders: conformation and aggregation properties of long polyglutamine peptides with and without interruptions.

Authors:  D Sharma; S Sharma; S Pasha; S K Brahmachari
Journal:  FEBS Lett       Date:  1999-07-30       Impact factor: 4.124

6.  Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease.

Authors:  S Y Kim; P Grant; J H Lee; H C Pant; P M Steinert
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

7.  Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei.

Authors:  M V Karpuj; H Garren; H Slunt; D L Price; J Gusella; M W Becher; L Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

8.  Nuclear translocation of tissue type transglutaminase during sphingosine-induced cell death: a novel aspect of the enzyme with DNA hydrolytic activity.

Authors:  Y Takeuchi; H Ohashi; P J Birckbichler; T Ikejima
Journal:  Z Naturforsch C J Biosci       Date:  1998 May-Jun

9.  Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases.

Authors:  V Gentile; C Sepe; M Calvani; M A Melone; R Cotrufo; A J Cooper; J P Blass; G Peluso
Journal:  Arch Biochem Biophys       Date:  1998-04-15       Impact factor: 4.013

10.  Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.

Authors:  M K Perez; H L Paulson; S J Pendse; S J Saionz; N M Bonini; R N Pittman
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

View more
  10 in total

1.  Tissue transglutaminase inhibits the TRPV5-dependent calcium transport in an N-glycosylation-dependent manner.

Authors:  Sandor Boros; Qi Xi; Henrik Dimke; Annemiete W van der Kemp; Kukiat Tudpor; Sjoerd Verkaart; Kyu Pil Lee; René J Bindels; Joost G Hoenderop
Journal:  Cell Mol Life Sci       Date:  2011-09-28       Impact factor: 9.261

Review 2.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 3.  Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1.

Authors:  Hyoungseok Ju; Hiroshi Kokubu; Janghoo Lim
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

4.  Inhibition of transglutaminase exacerbates polyglutamine-induced neurotoxicity by increasing the aggregation of mutant ataxin-3 in an SCA3 Drosophila model.

Authors:  Yunting Lin; Hua He; Yingying Luo; Ting Zhu; Ranhui Duan
Journal:  Neurotox Res       Date:  2014-12-11       Impact factor: 3.911

Review 5.  Pathogenic mechanisms underlying spinocerebellar ataxia type 1.

Authors:  Leon Tejwani; Janghoo Lim
Journal:  Cell Mol Life Sci       Date:  2020-04-18       Impact factor: 9.261

6.  Role of tissue transglutaminase type 2 in calbindin-D28k interaction with ataxin-1.

Authors:  P J S Vig; J Wei; Q Shao; M D Hebert; S H Subramony; L T Sutton
Journal:  Neurosci Lett       Date:  2007-04-05       Impact factor: 3.046

7.  Transglutaminase induces protofibril-like amyloid beta-protein assemblies that are protease-resistant and inhibit long-term potentiation.

Authors:  Dean M Hartley; Chaohui Zhao; Austin C Speier; Gavitt A Woodard; Shaomin Li; Zongli Li; Thomas Walz
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

Review 8.  Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death.

Authors:  H Tatsukawa; Y Furutani; K Hitomi; S Kojima
Journal:  Cell Death Dis       Date:  2016-06-02       Impact factor: 8.469

9.  Cross-species genetic screens identify transglutaminase 5 as a regulator of polyglutamine-expanded ataxin-1.

Authors:  Won-Seok Lee; Ismael Al-Ramahi; Hyun-Hwan Jeong; Youjin Jang; Tao Lin; Carolyn J Adamski; Laura A Lavery; Smruti Rath; Ronald Richman; Vitaliy V Bondar; Elizabeth Alcala; Jean-Pierre Revelli; Harry T Orr; Zhandong Liu; Juan Botas; Huda Y Zoghbi
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

Review 10.  Roles of Post-translational Modifications in Spinocerebellar Ataxias.

Authors:  Linlin Wan; Keqin Xu; Zhao Chen; Beisha Tang; Hong Jiang
Journal:  Front Cell Neurosci       Date:  2018-09-19       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.